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A B S T R A C T
Despite increased awareness of mental health problems, stigma persists. Little research has examined potential
health and wellbeing outcomes associated with stigma. The aim of this study was to investigate relationships
between mental health stigma, metabolic and cardiovascular biomarkers, as well as wellbeing and quality of life
among people with no mental disorder, common mental disorders and severe mental illness. Data were taken
from adults aged 16 + years participating in the Health Survey for England in 2014 (N = 5491). Mental health
stigma was measured using the 12-item Community Attitudes towards the Mentally Ill (CAMI) scale, intended to
measure attitudes around prejudice and exclusion, and tolerance and support for community care. Individuals
were divided into six groups based on their mental health (no mental disorder, common mental disorder, severe
mental illness) and whether they exhibited more (≤25th percentile) or less (> 25th percentile) stigmatising
attitudes. Metabolic and cardiovascular biomarker outcomes included systolic and diastolic blood pressure; total
cholesterol; high-density lipoprotein (HDL) cholesterol; glycated haemoglobin, body mass index (BMI), waist-hip
ratio and resting pulse rate. Biomarkers were analysed individually and as an allostatic load score. Wellbeing was
measured using Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) and quality of life via Euro-QoL-5D
(EQ-5D). Linear regression models were calculated adjusted for confounders. Compared to individuals with less
stigmatising attitudes, results suggested that those with more negative attitudes exhibited poorer wellbeing and
quality of life across all mental disorder/stigma groups, including those with no mental disorder (WEMWBS
(range 14–70): b= -1.384, 95% CI: -2.107 to -0.661). People with severe mental illness generally had un-
healthier biomarker proﬁles and allostatic load scores, but results were inconsistent for any additional inﬂuence
of mental health stigma. Reducing stigma may be beneﬁcial for population wellbeing, but further research is
needed to clarify whether stigma contributes to adverse biomarkers amongst people with mental illness.
1. Background
Mental health disorders (such as major depressive disorder and
anxiety disorders) are now a leading cause of disability worldwide (Vos
et al., 2017). Substantial inequalities exist in life expectancy for people
with severe mental illnesses (such as bipolar disorder and schizo-
phrenia), quantiﬁed at 8.0 to 14.6 life years lost for men and 9.8 to 17.5
life years lost for women (Chang et al., 2011). Despite this, research
that attempts to explain the premature and excess mortality and mor-
bidity observed for those with mental disorders has received com-
paratively little attention, in contrast to other major risk factors such as
diabetes and obesity. Stigma associated with mental illness is thought to
be a key contributing factor (Saxena, 2018).
Stigma is a fundamental social determinant of health that leads to
health inequalities (Hatzenbuehler, Phelan, & Link, 2013), yet there is a
lack of research relating to the role of stigma in patterning health. This
may be partly due to the inconsistent deﬁnition of stigma, the diﬃculty
in measuring the concept and the many circumstances in which stigma
has been used (Link & Phelan, 2001). Stigma can be understood as
applying to a wide range of circumstances not limited to mental illness,
such as welfare receipt (Besley & Coate, 1992), HIV and AIDS (Parker &
Aggleton, 2003), and lung cancer (Chapple, Ziebland, & McPherson,
2004). Link and Phelan conceptualise stigma as the co-occurrence of
several dimensions: labelling (when human diﬀerences are identiﬁed
and named), stereotyping (dominant cultural beliefs connect labelled
persons to undesirable characteristics), separation (labelled persons are
grouped to achieve division of “us” versus “them”), status loss, and
discrimination (Link & Phelan, 2001). They further stress that for
stigmatisation to happen, power must be exercised and that stigma can
lead to the unequal distribution of a variety of life chances including
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T
employment, housing and health (Link & Phelan, 2001). Within mental
health, several ways in which stigma can be expressed have been dis-
tinguished: public stigma; internalised or self-stigma; and structural
stigma.
Public stigma occurs when members of the general public endorse
prejudice and discrimination against people with mental illness (Rusch
& Thornicroft, 2014), such as believing people with mental disorders
are highly dangerous. Self-stigma occurs when people with mental ill-
ness endorse and internalise these negative stereotypes, which can re-
sult in a loss of self-worth, shame, and lead individuals to give up on life
goals (Rusch & Thornicroft, 2014), also known as the “why try” eﬀect
(Corrigan, Larson, & Rüsch, 2009). However, self-stigma is not in-
evitable. In diﬀerent situations people with mental illness may respond
to stigma with low self-esteem and diminished self-eﬃcacy, righteous
anger, or indiﬀerence (Corrigan & Watson, 2006). Some people may
ﬁnd their identity empowers them and that they can use their anger to
improve their own circumstances and help others. Indeed, research has
demonstrated that public stigma and self-stigma are correlated, but not
necessarily strongly associated (Bradstreet, Dodd, & Jones, 2018;
Chronister, Chou, & Liao, 2013). Structural, or institutional stigma,
occurs when policies, rules or regulations within society intentionally
marginalise the opportunities of those with mental disorders or produce
unintended consequences that hinder their prospects, resources and
wellbeing (Corrigan, Markowitz, & Watson, 2004; Hatzenbuehler,
2016; Rusch & Thornicroft, 2014). An example being the chronic under-
funding of mental health services (Corrigan & Watson, 2003).
Given the lack of a consistent deﬁnition of stigma and its various
forms, there is no consensus on how best to measure mental health
stigma and numerous methods have been used (Link, Yang, Phelan, &
Collins, 2004). A body of research has focussed on measuring public
stigma towards people with mental disorders and its evolution over
time. Data spanning ten years from 1996 to 2006 from the United States
has revealed no decrease in public stigma, measured by asking re-
spondents, for example, how willing they would be to have a person
with a mental illness work closely with them, or marry into the family
(Pescosolido et al., 2010). There was also a small increase in beliefs that
people with schizophrenia would likely be violent towards others. This
was supported by a study examining public attitudes across 8 years in
Australia, where an increase in the perception that people with mental
disorders are dangerous and unpredictable was observed (Reavley &
Jorm, 2012). A systematic review on this topic supports these ﬁndings;
despite improved population mental health literacy, the social rejection
of people with mental disorders has remained pervasive over the last 20
years and negative stereotypes relating to the dangerousness of people
with severe mental illness persists (Schomerus et al., 2012). In a study
examining public attitudinal trends associated with the implementation
of the Time to Change campaign to reduce mental health stigma and
discrimination in England, Evans-Lacko, Henderson, and Thornicroft
(2013) found little evidence for signiﬁcant long-term improvements in
knowledge and attitudes towards people with mental illness, or changes
in reported behaviour from 2009 to 2012. However, there was some
evidence to support improved intended behaviour, such as the intention
to live, work and have a relationship with someone who has a mental
illness. More recent evidence suggests progress has been made in re-
ducing levels of public mental health stigma between 2009 and 2017 in
England (Robinson & Henderson, 2018). Measures of public knowledge,
attitudes, desire for social distance and reporting having contact with
people with mental health problems have all shown improvements over
time.
Few studies have adopted a multilevel approach to mental health
stigma. One study that used data from 14 European countries found
that people with mental illness who resided in countries with less
stigmatising attitudes had lower rates of self-stigma and perceived
discrimination (Evans-Lacko, Brohan, Mojtabai, & Thornicroft, 2012).
Individuals who lived in countries where the public felt more comfor-
table interacting with people who had a mental illness also had lower
levels of self-stigma and felt more empowered. In this study self-stigma
was measured using the Internalised Stigma of Mental Illness Scale
(ISMI), which contains alienation, stereotype endorsement, perceived
discrimination and social withdrawal subscales.
Stigma has been associated with a range of outcomes amongst
people with mental illness. A systematic review demonstrated a strong
relationship between internalised stigma and poorer psychosocial out-
comes (including hope, self-esteem and empowerment), as well as
psychiatric symptom severity and poorer adherence to treatment
(Livingston & Boyd, 2010). Increased depressive symptoms and poorer
quality of life are also related to internalised stigma amongst those with
mental disorders (Mashiach-Eizenberg, Hasson-Ohayon, Yanos,
Lysaker, & Roe, 2013; Picco et al., 2016; Yanos, Roe, Markus, &
Lysaker, 2008). Stigma may also contribute towards suicidality and
suicide rates (Oexle, Waldmann, Staiger, Xu, & Rüsch, 2018; Rüsch,
Zlati, Black, & Thornicroft, 2014; Schomerus et al., 2015), impede re-
covery from mental illness (Wood, Byrne, Burke, Enache, & Morrison,
2017), and hamper eﬀorts to prevent mental disorders (Rusch &
Thornicroft, 2014). Holding stigmatising beliefs about people with
mental disorders is also related to less active help-seeking behaviour for
mental ill health (Schnyder, Panczak, Groth, & Schultze-Lutter, 2017).
However, a key gap in the literature relates to the lack of research fo-
cusing on possible objective health outcomes associated with self-
stigma. A diﬃculty of measuring the potential health eﬀects of self-
stigma is the lack of available indicators included in large scale health
surveys. An exception is the Health Survey for England (HSE), which
included the Community Attitudes Towards the Mentally Ill scale
(CAMI) in 2014, developed to measure public attitudes towards people
with mental illness (Taylor & Dear, 1981). The scale has been used
extensively to evaluate the Time to Change anti-stigma and dis-
crimination campaign (Evans-Lacko et al., 2013). One way to measure
aspects of self-stigma and its potential eﬀects on health is to assess the
extent of stereotype endorsement using the CAMI scale amongst people
with mental disorders and relate this to the range of health outcomes
included in the HSE.
To date, there have been no studies that have analysed the impact of
mental health stigma on biological indicators of health, or biomarkers.
A biomarker can be deﬁned as “a characteristic that is objectively mea-
sured and evaluated as an indicator of normal biological processes, patho-
genic processes, or pharmacologic responses to a therapeutic intervention”
(Biomarkers Deﬁnitions Working Group, 2001, p. 91). This covers a
variety of measures from pulse and blood pressure through to more
complex laboratory tests of blood to assess levels of cholesterol or in-
ﬂammatory markers (Strimbu & Tavel, 2010). Examining biomarker
data has several advantages. Biomarkers are not aﬀected by reporting
biases as is the case for self-reported outcomes. They can help to
identify individuals at an increased risk of health problems before
people are aware of problems themselves, and elucidate potential
causal mechanisms at play between social exposures and disease (Shih,
Fernandes, & Bird, 2010). Given that self-stigma is associated with di-
minished self-esteem, poorer mental health and quality of life, it could
be hypothesised to impact on biological indicators of health, particu-
larly those related to cardiovascular and metabolic health. This has
been demonstrated for other stressful experiences, such as informal
caregiving (Lacey, McMunn, & Webb, 2018), ﬁnancial insecurity
(Niedzwiedz, Katikireddi, Reeves, McKee, & Stuckler, 2017), threat of
redundancy (Mattiasson, Lindgärde, Nilsson, & Theorell, 1990), and
household debt (Sweet, Nandi, Adam, & McDade, 2013). Potential
stress associated with self-stigma, as well as perceived and anticipated
discrimination (Schafer & Ferraro, 2011), may operate directly on
metabolic and cardiovascular health via chronic physiological stress
responses or through poor health behaviours, such as a diet char-
acterised by high sugar and fat (Aschbacher et al., 2014), and a lack of
physical activity.
The process by which stigma may aﬀect biological systems could be
considered an example of embodiment. Embodiment is “a concept
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referring to how we literally incorporate, biologically, the material and social
world in which we live, from conception to death” (Krieger, 2001, p. 672).
It is a useful construct to theorise how social exposures ‘get under the
skin’, become biologically embedded and ultimately inﬂuence health
and health inequalities (Krieger & Davey Smith, 2004). Social epide-
miologists have drawn on embodiment to examine the potential bio-
logical pathways through which socioeconomic inequalities in health
may arise, such as via the inﬂammatory system (McCrory et al., 2019)
and allostatic load (Delpierre et al., 2016; McCrory et al., 2019). Allo-
static load has been proposed as a measure of the overall cost of
adapting to the environment and is usually operationalised as a com-
posite measure including various physiological systems which represent
physiological wear and tear (Delpierre et al., 2016). Markers included
in allostatic load scores often comprise blood pressure, pulse rate, body
mass index (BMI), and blood glucose, which are associated with me-
tabolic and cardiovascular diseases, as well as all-cause mortality
(Adams et al., 2009; Bhaskaran, dos-Santos-Silva, Leon, Douglas, &
Smeeth, 2018; Palatini & Julius, 2004). The composite allostatic load
scores have been found to predict mortality more accurately than the
individual indicators themselves (Delpierre et al., 2016; Seeman,
McEwen, Rowe, & Singer, 2001).
In this study, mental health stigma is conceptualised as a cumulative
social exposure which can become embodied to impact on cardiovas-
cular and metabolic function amongst people with mental illness. The
study aims to advance the evidence base on the relationship between
mental health stigma and health (measured by a range of metabolic and
cardiovascular biomarkers and an indicator of allostatic load) in a
general population sample. Previous research on the outcomes of
mental health stigma has often used only self-reported psychological
outcomes. To compare with previous research, measures of wellbeing
and quality of life are also included. The research questions and speciﬁc
hypotheses are detailed below:
1. What is the extent of mental health stigma amongst those with and
without mental disorders and are there diﬀerences between in-
dividuals with severe and common mental disorders?
• Individuals with mental disorders are hypothesised to display less
stigmatising attitudes compared to those with no experience of
mental illness.
2. Is mental health stigma associated with metabolic and cardiovas-
cular biomarkers, wellbeing and quality of life and does any re-
lationship diﬀer between individuals with and without mental dis-
orders?
• Mental health stigma is not expected to relate to health and
wellbeing in individuals with no diagnosed mental disorder.
Individuals with mental disorders who hold stigmatising attitudes
are hypothesised to have more adverse metabolic and cardiovas-
cular biomarker proﬁles and poorer wellbeing and quality of life
compared to those with no mental disorder and the associations
may be stronger amongst those with more severe mental illness.
2. Methods
2.1. Data
Data were taken from the 2014 round of the Health Survey for
England (HSE) (NatCen Social Research & University College London
Department of Epidemiology and Public Health, 2018, p. 7919) and are
available via the UK Data Service (https://www.ukdataservice.ac.uk/).
The HSE is a repeated cross-sectional survey, which has been conducted
annually since 1991. The sampling is based on a multi-stage stratiﬁed
random sample of individuals living in private households in England.
In the 2014 survey, the sample included 8077 adults (aged 16 years and
over) and 2003 children (aged 0–15 years), with a household response
rate of 62% (NatCen Social Research, 2014d). Each survey contains a
range of health and sociodemographic related questions collected via
face-to-face Computer Assisted Personal Interview (CAPI) and self-
completion methods, as well as measurements taken by a nurse (in-
cluding height, weight, waist circumference, blood pressure and urine,
blood and saliva samples) at a follow-up visit for consenting partici-
pants. In addition, each year contains diﬀerent modules focusing on a
speciﬁc topic. The 2014 survey included a self-completion module
dedicated to mental health, which was asked of adults only during the
nurse visit. Participants were included in this study if they completed
the follow-up nurse visit and were aged 16 years and over (N= 5491).
2.2. Independent variables
2.2.1. Deﬁnition of mental disorder
During the nurse visit participants were provided with a list of 17
mental health disorders and asked to select which ones they had ever
been diagnosed with by a health professional, at any point in their life
(Bridges, 2015). Due to the low prevalence of speciﬁc disorders, they
were grouped into common mental disorders (phobia, panic attacks,
post-traumatic stress, generalised anxiety disorder, depression, post-
natal depression or obsessive compulsive disorder), severe mental ill-
nesses (bipolar disorder, eating disorder, nervous breakdown, person-
ality disorder, psychosis or schizophrenia) or other complex mental
illness (attention deﬁcit hyperactivity disorder, attention deﬁcit dis-
order, dementia, seasonal aﬀective disorder, alcohol or drug depen-
dence, or any other mental, emotional or neurological problem or
condition). Respondents may have reported having more than one
disorder and there is signiﬁcant overlap across categories (Bridges,
2015). Participants were grouped into those who did not report a di-
agnosed mental disorder, those who reported a common mental dis-
order or other complex mental illness (due to the small number of
participants in the latter group), and those who reported a severe
mental illness. Individuals who reported having both a severe mental
illness and a common mental disorder (or other complex mental illness)
were classiﬁed as having a severe mental illness.
2.2.2. Measurement of mental health stigma
Mental health stigma was measured using the Community Attitudes
toward the Mentally Ill (CAMI) scale. The original CAMI questionnaire
contained 40 statements relating to mental illness (e.g. “it is frightening
to think of people with mental problems living in residential neighbourhoods”
and “mental illness is an illness like any other”) (Taylor & Dear, 1981)
NatCen Social Research, 2014b). The 2014 HSE contained a shortened
12-item scale containing items designed to measure mental health
stigma and tolerance, which participants aged 16 + years were asked
to self-complete (Ilic, Henderson, Henderson, Evans-Lacko, &
Thornicroft, 2015). The 12-tem CAMI scale has been used in previous
research evaluating the impact of the Time to Change social marketing
campaign (Sampogna et al., 2017).
The HSE team conducted factor analysis on the scale, which re-
vealed a two-factor structure relating to prejudice and exclusion and
tolerance and support for community care. Participants were asked to
rate how much they agreed or disagreed with each statement on a 5-
point Likert Scale, which was scored as follows for positive statements:
agree strongly (100), agree slightly (75), neither agree nor disagree
(50), disagree slightly (25), disagree strongly (0). Participants were also
given the option to answer “don’t know”, but these were excluded from
the analysis. Negatively worded statements were reverse scored so that
for each item, the mean scores ranged from 0 to 100, where a higher
score corresponds to a more positive attitude (i.e. less prejudiced and
more tolerant) (Ilic et al., 2015). A composite score (ranging from 0 to
100) was then calculated for each factor which was derived from the
mean of the six items relating to each factor. Participants were included
in the composite score if they answered (i.e. not responded “don’t
know”) at least two of the six statements relating to each factor (Ilic
et al., 2015). Two binary variables were then derived distinguishing
those who scored≤ the 25th percentile on both CAMI scales as
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indicators of more stigmatising attitudes and those who scored > the
25th percentile as less stigmatising attitudes. Amongst people with
mental illness, the former variables therefore represent a key aspect of
self-stigma, the endorsement of negative stereotypes.
2.3. Outcomes
Eight biomarkers were included as outcomes: glycated haemoglobin
(HbA1c), total cholesterol, high-density lipoprotein (HDL) cholesterol,
systolic and diastolic blood pressure, resting pulse rate, body mass
index (BMI) and waist-hip ratio. Resting pulse rate, systolic and dia-
stolic blood pressure are measures of cardiovascular function, whereas
HbA1c, cholesterol, BMI and waist-hip ratio are indicators of metabolic
function. Non-fasting blood samples were taken from participants at the
time of the nurse visit and were sent to the labs at the Royal Victoria
Hospital in Newcastle for analysis. Glycated haemoglobin (mmol/mol),
total cholesterol (mmol/L) and HDL-cholesterol (mmol/L) values were
derived by procedures outlined elsewhere (NatCen Social Research,
2014a). Systolic and diastolic blood pressure measurements (mmHg)
were also taken from participants during the nurse visit using an Omron
HEM 907 blood pressure monitor after the participants had been sitting
quietly for 5minutes (NatCen Social Research, 2014c). Three mea-
surements were taken and the mean value of the second and third
measurements was used. As recommended (Cui, Hopper, & Harrap,
2003; Lacey et al., 2018), 10mmHg and 5mmHg were added to the
systolic blood pressures and diastolic blood pressures of individuals
who reported they had taken antihypertensive medications in the past
seven days, respectively. Resting pulse rate (bpm) was also recorded
using the Omron HEM 907 three times, the ﬁrst value was used due to
the increase in pulse rate across the three measurements. In line with
previous research, 1.18mmol/L was added to total cholesterol if an
individual reported taking statins, 4% was subtracted if they reported
taking diuretics, 10% was added to HDL-cholesterol if they reported
taking beta blockers and 1% was added to HbA1c if they reported
taking insulin or any other anti-diabetic medications (Robertson et al.,
2014, 2017). Measurements of height, weight, waist and hip cir-
cumference were also taken from participants, enabling the calculation
of BMI (weight in kg/height in m2) and waist-hip ratio (waist cir-
cumference in cm/hip circumference in cm).
Additionally, for each of the eight biomarkers, participants were
classiﬁed into sex-speciﬁc quartiles based on the distribution of scores.
Individuals who fell into top quartile (for HbA1c, total cholesterol, BMI
and waist-hip ratio, resting pulse rate, systolic and diastolic blood
pressure) or bottom quartile (for HDL-cholesterol) were classed as ‘high
risk’ and given a score of 1 and the remaining sample was given a score
of 0. From that, a measure of allostatic load was calculated from the
sum of each binary biomarker variable (ranging from 0 to 8). This
method used to derive the allostatic load score has been used in nu-
merous previous studies (McCrory et al., 2019; Robertson et al., 2017;
Seeman et al., 2001). Individuals were included in the score if they had
at least four complete biomarkers and excluded if they had missing
values for more than four biomarkers. Sensitivity analyses excluding
those missing more than four biomarkers did not aﬀect the substantive
results.
Two measures of wellbeing and quality of life were included. Mental
wellbeing was measured using the Warwick-Edinburgh Mental Well-
Being Scale (WEMWBS) (Tennant et al., 2007), in which participants
are asked to tick the box that best describes their experience (e.g.
feeling useful, relaxed and thinking clearly) over the last two weeks on
a scale from none of the time, rarely, some of the time, often, or all of
the time. Quality of life was measured using the EuroQol-5D (EQ-5D)
scale, which asseses ﬁve dimensions: mobility; ability to carry out usual
activities; self-care; pain/discomfort; anxiety/depression (EuroQol
Group, 1990). Participants are asked to rate whether they had ‘no
problem’, ‘some problem’ or an ‘extreme problem’ with each dimension.
The HSE team converted answers to a single utility value based on a
British EQ-5D scoring algorithm and weighted according to the social
preference of the UK population (Søltoft, Hammer, & Kragh, 2009). For
both WEMWBS (range 14–70) and EQ-5D (range -0.33 to 1.00) higher
scores reﬂected more positive outcomes.
2.4. Covariates
Age in years, gender (male versus female), ethnicity (white versus
non-white), marital/partnership status (married/cohabiting/civil part-
nership, single, divorced/separated, or widowed), education level and
social class were included as potential confounding variables. Highest
education level was categorised as degree level or equivalent; A Level or
equivalent; General Certiﬁcate of Secondary Education (GCSE) or
equivalent; no qualiﬁcations. Social class (household) was categorised
as managerial and professional occupations; intermediate occupations;
or routine and manual occupations (including households who were not
currently employed), according to the National Statistics Socio-eco-
nomic Classiﬁcation (NS-SEC) three-category social class classiﬁcation
scheme.
2.5. Statistical analysis
Firstly, descriptive statistics of the key variables were examined in
this cross-sectional analysis. Relevant weights were applied to account
for non-response and selection into the diﬀerent elements of the survey
(e.g. the nurse visit and blood sample groups). Glycated haemoglobin
values were logged due to their skewed distribution and when results
from these models are presented their exponentiated coeﬃcients are
shown to help with the interpretation. First, the association between
mental disorders (deﬁned as a categorical variable comparing those
with no mental disorder, a common mental disorder, or a severe mental
illness) and mental health stigma (including the two attitudinal mea-
sures in turn as binary outcome variables) was assessed using logistic
regression, adjusted for the covariates: age, gender, education level,
social class, ethnicity and marital status. Next, the association between
mental disorder, stigma and each biomarker and wellbeing outcome
was examined using linear regression, adjusted for the covariates. Six
mental disorder/stigma groups were derived: individuals with no
mental disorder/less stigmatising attitudes (> 25th percentile); no
mental disorder/more stigmatising attitudes (≤25th percentile);
common mental disorder/less stigmatising attitudes; common mental
disorder/more stigmatising attitudes; severe mental disorder/less stig-
matising attitudes; severe mental disorder/more stigmatising attitudes.
The standardised beta coeﬃcients from these models were also calcu-
lated and graphed to help interpret the pattern of results, eﬀect sizes
and direction of associations.
All statistical models adjusted for household clustering. Missing data
for the independent variables and covariates (N= 524) were excluded
from the analysis. Each statistical model may contain a diﬀerent
number of individuals as participants who had complete data for at
least one outcome variable were included. Statistical analyses were
conducted using Stata/MP 15.1.
3. Results
3.1. Sample description
A total of 4967 individuals were included in the analysis sample
(excluding participants with missing data), 51.5% were female
(Table 1). The mean age of participants was 46.7 (SD=18.7). 73.2%
(N=3635) of the sample reported having no diagnosed mental dis-
order, 22.3% (N=1110) a common mental disorder and 4.5%
(N=222) a severe mental illness. 32.2% (N=1600) of the sample
exhibited more stigmatising attitudes towards mental health according
to the tolerance and support for community care measure, compared to
25.5% (N=1267) using the prejudice and exclusion measure.
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Descriptive statistics for the outcome variables are found in Table A1.
3.2. Mental health stigma
Individuals with experience of a common mental disorder or severe
mental illness were less likely to exhibit stigmatising attitudes com-
pared to those with no mental disorder (Table 2). Using the measure of
tolerance and support for community care, individuals with a common
mental disorder (OR=0.648, 95% CI: 0.546 to 0.770) were slightly
less likely to have stigmatising attitudes than those with a severe mental
illness (OR=0.669, 95% 0.465 to 0.963), but using the measure of
prejudice and exclusion results were equivalent. Women were also less
likely to hold stigmatising attitudes compared to men, as well as those
with a more advantaged socioeconomic position, according to both
education level and social class. Non-white ethnic groups exhibited
more stigmatising attitudes particularly in relation to the measure of
prejudice and exclusion.
3.3. Metabolic and cardiovascular biomarkers
A mixed pattern of results was found for the metabolic and cardi-
ovascular biomarkers (Fig. 1 and Fig. 2). Inconclusive results were
found for the cardiovascular biomarkers, systolic and diastolic blood
pressure (Table 3, full results available in Tables A2 and A3). In-
dividuals with severe mental illness generally displayed higher resting
pulse rates compared to those with a common mental disorder, and
those with a common mental disorder exhibited higher values
compared to those with no disorder. However, there were no notable
diﬀerences dependent on the degree of mental health stigma possessed.
Similar results were found for the metabolic biomarkers. For waist-hip
ratio, glycated haemoglobin, and cholesterol, in general, more adverse
biomarker levels were found with increased severity of mental illness,
but little consistent diﬀerences were observed between stigma groups.
Amongst those with severe mental illness, those with more stigmatising
attitudes according to the measure of tolerance and support for com-
munity care exhibited higher levels of glycated haemoglobin (ex-
ponentiated coeﬃcient= 1.042, 95% CI: 0.986 to 1.101), compared to
those with less stigmatising attitudes (1.023, 95% CI: 0.985 to 1.062),
but this was not found for the other measure of stigma and diﬀerences
were not statistically signiﬁcant. Likewise, for waist-hip ratio and BMI,
higher values were observed for those with severe mental illness who
displayed more stigmatising attitudes, compared to those with less
stigmatising attitudes, but this was only observed for the measure of
stigma related to prejudice and exclusion.
3.4. Allostatic load
No clear pattern of results was found for allostatic load (Figs. 1 and
2). Individuals with common mental disorders generally exhibited
higher allostatic load scores compared to those with no history of
mental disorder, and those with severe mental illness had higher scores
than those with a common mental disorder (Table 3, full results
available in Tables A2 and A3). For example, amongst individuals
displaying less stigmatising attitudes according to the measure of
stigma relating to tolerance and support for community care, those with
a common mental disorder had higher allostatic load scores compared
to those with no disorder (b= 0.269, 95% CI: 0.125 to 0.413), and
those with a severe mental illness had even higher scores (b=0.475,
95% CI: 0.098 to 0.852). However, no consistent diﬀerences were ap-
parent between those with higher and lower levels of mental health
stigma.
Table 1
Descriptive statistics for the sample (weighted).
Variable Mean SD
Age (years) 46.7 18.7
Gender N %
Male 2409 48.5
Female 2558 51.5
Mental disorder/stigma group (tolerance & support for
community care)
N %
No MD/less stigmatising attitudes 2368 47.7
No MD/more stigmatising attitudes 1267 25.5
CMD/less stigmatising attitudes 837 16.9
CMD/more stigmatising attitudes 273 5.5
SMI/less stigmatising attitudes 162 3.3
SMI/more stigmatising attitudes 60 1.2
Mental disorder/stigma group (prejudice & exclusion) N %
No MD/less stigmatising attitudes 2611 52.6
No MD/more stigmatising attitudes 1025 20.6
CMD/less stigmatising attitudes 913 18.4
CMD/more stigmatising attitudes 197 4.0
SMI/less stigmatising attitudes 177 3.6
SMI/more stigmatising attitudes 45 0.9
Education Level N %
Degree 1395 28.1
A Level 1442 29.0
GCSE 1217 24.5
None 913 18.4
Ethnicity N %
White 4428 89.1
Non-white 539 10.9
Marital status N %
Single 1155 23.2
Married 3091 62.2
Divorced 425 8.6
Widowed 296 6.0
Social class N %
Managerial and professional occupations 2086 42.0
Intermediate occupations 1063 21.4
Routine and manual occupations 1818 36.6
Total 4967 100
CMD=common mental disorder; GCSE=General Certiﬁcate of Secondary
Education; MD=mental disorder; N= number of individuals; SD= standard
deviation; SMI= severe mental illness.
Table 2
Results from logistic regression models assessing the likelihood of more stig-
matising attitudes (≤25th percentile) according to mental disorder group.
Tolerance & support for
community care
Prejudice & exclusion
OR [95% CI] OR [95% CI]
Gender (ref=male)
Female 0.765∗∗∗ [0.667,0.877] 0.588∗∗∗ [0.503,0.686]
Age 0.983∗∗∗ [0.978,0.988] 1.004 [0.999,1.010]
Mental disorder (ref= none)
Common mental
disorder
0.648∗∗∗ [0.546,0.770] 0.627∗∗∗ [0.519,0.756]
Severe mental illness 0.669∗ [0.465,0.963] 0.627∗ [0.437,0.898]
Education level (ref= degree)
A Level 1.342∗∗ [1.083,1.663] 1.117 [0.874,1.427]
GCSE 1.494∗∗∗ [1.192,1.872] 1.418∗∗ [1.101,1.826]
None 1.944∗∗∗ [1.502,2.515] 2.311∗∗∗ [1.755,3.045]
Ethnicity (ref=white)
Non-white 1.523∗∗ [1.153,2.011] 3.047∗∗∗ [2.279,4.075]
Marital status (ref=married)
Single 1.072 [0.866,1.328] 0.927 [0.728,1.181]
Divorced 1.076 [0.846,1.368] 1.194 [0.935,1.524]
Widowed 1.269 [0.960,1.677] 1.470∗∗ [1.109,1.950]
Social class (ref=Managerial & professional)
Intermediate 1.435∗∗∗ [1.162,1.771] 1.446∗∗ [1.149,1.821]
Routine and manual 1.589∗∗∗ [1.303,1.938] 2.073∗∗∗ [1.677,2.564]
∗p < 0.05.
∗∗p < 0.01.
∗∗∗p < 0.001.
CI= conﬁdence interval; GSCE=General Certiﬁcate of Secondary Education;
OR=odds ratio; Ref= reference category.
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3.5. Wellbeing and quality of life
A clearer pattern of results was found for the measures of wellbeing
and quality of life (Fig. 3). Compared to individuals with less stigma-
tising attitudes, those with more stigmatising attitudes generally ex-
hibited poorer scores across all mental disorder/stigma groups (Table 4,
full results available in Tables A2 and A3). Two exceptions were found
amongst those with severe mental illness. Those who exhibited more
stigmatising attitudes had slightly better quality of life when stigma was
measured using the tolerance and support for community care indicator
and slightly better wellbeing when using the prejudice and exclusion
indicator, compared to those exhibiting less stigmatising attitudes. It
Fig. 1. Standardised beta coeﬃcients derived from linear regression models for each biomarker according to mental disorder/stigma group for the tolerance and
support for community care measure. Note: BMI=Body Mass Index; CMD=common mental disorder; HDL=high density lipoprotein; MD=mental disorder;
SMI= severe mental illness.
Fig. 2. Standardised beta coeﬃcients derived from linear regression models for each biomarker according to mental disorder/stigma group for the prejudice and
exclusion measure. Note: BMI=Body Mass Index; CMD=common mental disorder; HDL=high density lipoprotein; MD=mental disorder; SMI= severe mental
illness.
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was interesting to note that, when using the tolerance and support for
community care indicator of stigma, worse wellbeing was apparent
among those with more stigmatising attitudes compared to those with
less stigmatising attitudes even amongst those with no experience of a
mental disorder (b= -1.384, 95% CI: -2.107 to -0.661).
4. Discussion
4.1. Summary
This study is the ﬁrst to investigate the association between mental
health stigma and a range of metabolic and cardiovascular biomarkers,
alongside measures of wellbeing and quality of life in a general popu-
lation sample. Less stigmatising attitudes were found amongst those
with experience of mental ill health. A potential negative inﬂuence of
mental health stigma was suggested for the measures of wellbeing and
quality of life. Even for those with no mental disorder, individuals with
more stigmatising attitudes had lower wellbeing compared to those
with more positive attitudes and there was some indication that well-
being and quality of life were worse amongst those with more stigma-
tising attitudes in each mental disorder group. The results for the me-
tabolic and cardiovascular biomarkers were less convincing and often
diﬀered depending on the measure of stigma being used. There was
evidence that those with more severe mental illness had more adverse
levels of several biomarkers compared to those with a common mental
disorder, and those with a common mental disorder generally had a
better biomarker proﬁle compared to those with no history of mental
disorder. However, results were inconsistent for any additional inﬂu-
ence of mental health stigma. Similarly, ﬁndings for allostatic load were
mixed with regards to mental health stigma, but individuals with ex-
perience of a mental disorder had higher scores compared to those with
no history.
Fig. 3. Standardised beta coeﬃcients derived from linear regression models for wellbeing and quality of life according to mental disorder/stigma group. Note:
CMD=common mental disorder; MD = mental disorder; SMI= severe mental illnes.
Table 4
Results from linear regression models assessing the association between mental disorder/stigma group and wellbeing and quality of life.
WEMWBS EQ5D WEMWBS EQ5D
Coeﬀ. [95% CI] Coeﬀ. [95% CI] Coeﬀ. [95% CI] Coeﬀ. [95% CI]
Tolerance & support for community care a Prejudice & exclusion a
No MD/more stigmatising attitudes -1.384∗∗∗ [-2.107,-0.661] -0.002 [-0.016,0.013] -0.688 [-1.558,0.183] -0.002 [-0.017,0.014]
CMD/less stigmatising attitudes -4.661∗∗∗ [-5.426,-3.895] -0.106∗∗∗ [-0.126,-0.086] -4.373∗∗∗ [-5.101,-3.645] -0.103∗∗∗ [-0.122,-0.084]
CMD/more stigmatising attitudes -5.798∗∗∗ [-6.988,-4.608] -0.127∗∗∗ [-0.161,-0.092] -5.897∗∗∗ [-7.302,-4.493] -0.147∗∗∗ [-0.189,-0.105]
SMI/less stigmatising attitudes -8.670∗∗∗ [-10.478,-6.862] -0.238∗∗∗ [-0.294,-0.183] -9.140∗∗∗ [-10.912,-7.367] -0.228∗∗∗ [-0.279,-0.177]
SMI/more stigmatising attitudes -10.312∗∗∗ [-13.554,-7.070] -0.232∗∗∗ [-0.325,-0.138] -7.579∗∗∗ [-11.262,-3.896] -0.272∗∗∗ [-0.389,-0.155]
N 4792 4871 4792 4871
CI= conﬁdence interval; CMD=common mental disorder; Coeﬀ. = unstandardised coeﬃcient; EQ5D=EuroQol-5D; MD = mental disorder; N= number of in-
dividuals; SMI= severe mental illness; WEMWBS=Warwick-Edinburgh Mental Well-Being Scale.
∗p < 0.05.
∗∗p < 0.01.
∗∗∗p < 0.001.
All models adjusted for gender, age, education level, ethnicity, social class and marital status.
a Reference category is no MD/less stigmatising attitudes.
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Previous research has demonstrated that mental health stigma is
related to wellbeing, life satisfaction and quality of life among people
with mental illness (Markowitz, 1998; Park, Bennett, Couture, &
Blanchard, 2013; Picco et al., 2016). Our ﬁndings add to and expand on
this literature, suggesting that more stigmatising attitudes relate to
poorer wellbeing and quality of life amongst those with mental dis-
orders and associations may be stronger amongst those with severe
mental illness. A novel ﬁnding of this paper which has not been ex-
amined before relates to the lower levels of wellbeing amongst those
with no history of mental disorder who hold more stigmatising atti-
tudes, compared to people who hold more positive attitudes. One
contributing factor that merits further research may be mental health
literacy, which has been shown to relate to higher wellbeing, and may
inﬂuence help-seeking behaviour and positive coping skills (Bjørnsen,
Espnes, Eilertsen, Ringdal, & Moksnes, 2017; Gulliver, Griﬃths, &
Christensen, 2010; Riebschleger, Costello, Cavanaugh, & Grové, 2019).
4.2. Strengths and limitations
A key strength of this study was the use of nationally representative
data for England, obtained via the Health Survey for England. The
analysis also used several diﬀerent measures of metabolic and cardio-
vascular function and two measures of wellbeing and quality of life, as
well as two indicators of mental health stigma, which are widely used
and validated measures. The deﬁnition of mental health disorders also
focused on lifetime diagnosed conditions, which is an improvement on
some studies which often deﬁne mental ill-health based on a cut-oﬀ
point using a scale measuring recent psychological distress, such as the
General Health Questionnaire (Katikireddi, Niedzwiedz, & Popham,
2012). The analysis also included a range of potential confounding
factors, although the possibility of unmeasured confounding cannot be
eliminated.
This study has a few limitations that should be acknowledged. The
deﬁnition of a mental disorder was based on self-reported diagnosis,
which itself could be aﬀected by stigma. Stigma could inﬂuence the
disclosure of a diagnosed mental disorder within the survey and some
individuals may have experienced mental ill health, but not sought a
diagnosis. Although a validated measure of mental health stigma was
used, answers to the questionnaire may be subject to social desirability
bias (Henderson, Evans-Lacko, Flach, & Thornicroft, 2012). The CAMI
also does not measure personal experience of self-stigma, such as the
experience of shame and discrimination related to mental health dis-
orders, which has been found to strongly associate with comorbid de-
pression and anxiety (Alonso et al., 2008). It may be possible that dif-
ferent results may be obtained depending on the measure of stigma
used. The measure of mental health stigma used in this study is in-
tended to measure public stigma and self-stigma was implied via low
CAMI scores (i.e. the endorsement of stigmatising stereotypes) amongst
those who experienced a mental disorder. It does not measure the in-
ternalisation of stigmatising beliefs; it is possible to hold stigmatising
attitudes towards other people with mental disorders but not apply or
internalise them personally.
People at the most severe end of mental illness may be less likely to
participate in health surveys and stigma may aﬀect participation in
surveys, the choice to complete the mental health questionnaires, and
the answers provided (Woodall, Morgan, Sloan, & Howard, 2010). In
addition, some of the included analyses comparing diﬀerences between
severe and common mental disorders were underpowered due to the
small number of people with a severe mental illness. Reverse causation
also cannot be ruled out especially for the measures of wellbeing as
those with poorer mental health may attribute this to stigma. The cross-
sectional design of the study also precludes any inference of potential
causal eﬀects; longitudinal data are needed to investigate the research
questions in more depth. At present, there are a lack of longitudinal
data collected on mental health stigma and even fewer which also
collect biomarker health data. The measure of allostatic load used in
this study also only covered metabolic and cardiovascular function.
4.3. Conclusions
This study highlights the need for more research into the potential
relationships between stigma, health and wellbeing. It is likely that
multiple stigma processes operate in a complex manner. This includes
stigma related to mental health, but also associated with other minority
and disadvantaged statuses related to, for example, gender, ethnicity,
sexual orientation, socioeconomic position, physical illness and dis-
abilities. Therefore, future research would beneﬁt from taking an in-
tersectional approach to stigma to analyse how diﬀerent stigmatised
statuses interact to inﬂuence health and health inequalities. There is
also a need to consider stigma at multiple levels (e.g. self-stigma, public
stigma and structural stigma) and how these might interact to inﬂuence
individual and population health. Longitudinal research that adopts a
life course perspective and examines the evolution of mental health
stigma through time within the same individuals to investigate whether
there are particular critical periods in the life course (e.g. adolescence)
that matter more for future health and social outcomes would also be
valuable.
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